|Description||Heart Disease Medical Devices|
|Series B, 10/09 |
Oxford Bioscience Partners
Tullis Health Investors
Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO.
The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in 2006. The company is based in Salt Lake City, Utah.